N. Sugiyama

发表

Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: a postmarketing surveillance report

T. Kokubo, Yasuo Suzuki, N. Sugiyama, 2020, Modern rheumatology.

RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report

T. Kokubo, Yasuo Suzuki, N. Sugiyama, 2020, Modern rheumatology.

A New Disease Concept in the Age of Processed Foods—Phosphorus-Burden Disease; including CKD–MBD Concrete Analysis and the Way to Solution

N. Sugiyama, Koichi Okada, K. Nishime, 2021, Nutrients.

Radiographic and clinical outcomes following etanercept monotherapy in Japanese methotrexate-naïve patients with active rheumatoid arthritis

N. Miyasaka, T. Takeuchi, R. Pedersen, 2020, Modern rheumatology.

Radiographic and clinical effects of 10 mg and 25 mg twice-weekly etanercept over 52 weeks in Japanese patients with active rheumatoid arthritis

N. Miyasaka, T. Takeuchi, R. Pedersen, 2020, Modern rheumatology.

A New Disease Concept in the Age of Processed Foods—Phosphorus-Burden Disease; CKD–MBD Concrete Analysis and the Way to Solution

N. Sugiyama, Koichi Okada, K. Nishime, 2021 .

Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials

N. Miyasaka, T. Takeuchi, J. Wajdula, 2014, Modern rheumatology.

AB0495 Post-marketing surveillance of tofacitinib in japanese patients with rheumatoid arthritis: an interim report of safety data

T. Mimori, S. Momohara, H. Matsuno, 2018, Rheumatoid arthritis – non biologic treatment and small molecules.

AB0431 Post-marketing surveillance of tofacitinib in japanese patients with rheumatoid arthritis: an interim report of safety data

T. Mimori, S. Momohara, H. Matsuno, 2017 .

Inhaling gas with different CT densities allows detection of abnormalities in the lung periphery of patients with smoking-induced COPD.

K. Soejima, K. Yamaguchi, N. Sugiyama, 2001, Chest.

Drug use investigation on the safety and efficacy of tigecycline in Japan (all-case post-marketing surveillance).

N. Sugiyama, Yukari Yoshinaga, Takahisa Ohashi, 2022, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance

H. Yamanaka, N. Miyasaka, N. Sugiyama, 2018, Modern rheumatology.

Post-marketing surveillance of high-dose methotrexate (>8 mg/week) in Japanese patients with rheumatoid arthritis: A post hoc sub-analysis of patients according to duration of prior methotrexate use

Yasuo Suzuki, N. Sugiyama, T. Hirose, 2020, Modern rheumatology.

Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials

J. Wajdula, Y. Kawano, M. Mori, 2011, Modern rheumatology.

Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan

J. Wajdula, Y. Kawano, M. Mori, 2012, Modern rheumatology.

Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance

T. Kokubo, M. Mori, S. Takei, 2018, Modern rheumatology.

Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials

J. Wajdula, Y. Kawano, M. Mori, 2011, Modern rheumatology.